期刊文献+

健脾化痰活血法结合西药治疗2型糖尿病合并高脂血症疗效观察 被引量:7

Combination of strengthening spleen,eliminating phlegm and activating blood circulation method and western medicine for the treatment of type 2 diabetic hyperlipemia
下载PDF
导出
摘要 目的观察健脾化痰活血法结合西药治疗2型糖尿病合并高脂血症的临床疗效。方法将87例患者随机分为观察组(45例)和对照组(42例)。两组均予二甲双胍肠溶片和阿托伐他汀钙片治疗,观察组同时加用健脾化痰活血中药。两组疗程均为3个月,观察临床疗效及血糖、血脂指标变化情况。结果观察组、对照组总有效率分别为95.56%、80.95%;组间临床疗效比较,差异有统计学意义(P<0.05)。两组治疗前后组内比较,血脂(TC、TG、LDL-C、HDL-C)差异均有统计学意义(P<0.05),血糖(FPG、2 hPG)差异无统计学意义(P>0.05);组间治疗后比较,TC、TG和HDL-C差异有统计学意义(P<0.05)。结论健脾化痰活血中药联合西药二甲双胍肠溶片和阿托伐他汀钙片用于治疗2型糖尿病合并高脂血症,临床疗效良好,在改善临床症状和降低血脂方面优于单纯西药。 Objective To observe the clinical efficacy of strengthening spleen, eliminating phlegm and activating blood circulation method combined with western medicine in treating type 2 diabetic hyperlipemia. Methods Eighty-seven cases were randomly divided into observation group ( 45 cases ) and control group (42 cases). Both of the groups were treated with Diformin Tablet and Atorvastatin Calcium Tablet, and observation group was treated by Chinese medicine additionally, with the course of 3 months. The clinical efficacy, blood sugar and indicator of serum lipid were observed. Results The overall effective rate was 95.56% in the treatment group and 80.95% in the control group, with a difference between the two groups (P 〈0.05 ). Before and after treatment, there were significant differences in blood lipid ( TC, TG, LDL-C, HDL-C ) in each group ( P 〈 0.05 ), and no significant difference was found in blood sugar ( FPG, 2 hPG) ( P 〉 0.05 ) ; after treatment, there were significant differences in TC, TG and HDL-C between the two groups ( P 〈 0.05 ). Conclusion Combined Chinese medicine with strengthening spleen, eliminating phlegm and activating blood circulation functions and western medicine together has positive effect on type 2 diabetic hyperlipemia. Its therapeutic effect is better than the western medicine in improving clinical symptoms and reducing blood lipid aspects.
作者 韩为民
出处 《上海中医药杂志》 2013年第8期42-43,共2页 Shanghai Journal of Traditional Chinese Medicine
关键词 2型糖尿病 高脂血症 中西医结合疗法 健脾化痰活血 type 2 diabetes hyperlipidemia combined therapy of Chinese and western medicines strengthening spleen, eliminating phlegm and activating blood
  • 相关文献

参考文献7

二级参考文献19

  • 1NAKAGAWA K, KISHIDA H, ARAI NAOKI, et al. Licorice Flavonoids Suppress Abdominal Fat Accumulation and Increase in Blood Glucose Level Obese Diabetic KK-Ay Mice [J]. Biol Pharm Bull, 2004, 27(11): 1775-1778.
  • 2AOKI F, HONDA S, KISHDA H. Suppression by Licorice flavonoids of abdominal fat accumulation and body weight gain in high-fal diet-induced obese C57BL/6J mice [J]. Biosei Biotechnol Bioehem, 2007, 71(1): 206-214.
  • 3FUHRMAN B, VOLKOVA N, KAPLAN M, et al. Antiatherosclerotic effects of licorice extract supplementatian on hypercholesterolemic patients: increased resistance of LDL to atherogenic modifications, reduced plasma lipid levels, and decreased systolic blood pressure[J]. Nutrition, 2002, 18(3): 268-273.
  • 4MAE T, KISHIDA H, NISHIYAMA T, et al. A licorice ethanolic extract with peroxisome proliferator-Activated Receptor-γ Lig- and-Binding activity affects diabetes in KK-Ay mice, abdominal obesity in diet-induced obese C57BL mice and hypertension in spontaneously hypertensive rats [J]. Nutrition, 2003, 133(11): 3369-3377.
  • 5KAPLAN F, A1-MAJALI K, BETTERIDGE DJ. PPARS, insulin resistance and type 2 diabetes [J]. J Cardiovasc Risk, 2001, 8(4): 211-217.
  • 6GUPTA A, TEN S, ANHALT H. Serum levels of soluble minor necrosis factor-alpha receptor 2 are linked to insulin resistance and glucose intolerance in children [J]. J Pediatr Endocrinol Metab, 2005, 18(1): 75-82.
  • 7INOUE M, YANO M, YAMAKADO M, et al. Relationship between the adiponecfin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia [J]. Metabolism, 2006, 55(9): 1248-1254.
  • 8CHEN JZ. Comparison of relationship between free fatty acid, plasma glucose and insulin resistance in Patients with type 2 diabetes meUitus[J]. Practical Clin Med, 2005, 6 (4): 13-15.
  • 9CERIEI,LO A, MOTZ E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited [J]. Arterioscler Thromb Vase Biol, 2004, 24(5): 816-823.
  • 10AOKI F, NAKAGAWA K, KITANO M, et al. Clinical safety of licorice flavonoid oil (LFO) and pharmacokinetics of glabridin in healthy humans[J]. J Am Coil Nutr, 2007, 26(3): 209-218.

共引文献4895

同被引文献91

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部